gvtcx

Manufacturing Execution System (MES) software for CGCT pre-GMP Advanced Therapies Digital & Automation Productivity Testbed

Catapult CT Published 28 Mar 2024 Find a Tender

key details

Statuscomplete
Category (CPV) 72212323
RegionEast of England
Procedurelimited
OCIDocds-h6vhtk-044e2e

Award

SupplierValueDateStatus
Autolomous Ltd · · active

description

Provision of a Manufacturing Execution System (MES) tailored explicitly for the field of cell therapies, The MES platform should enable resource scheduling, inventory optimisation, management & execution of electronic batch records and overall manufacturing workflows, review and release activities. All workflows should be client-configurable and controlled, through the use of a zero-code, platform-embedded, builder configuration tool. The platform should be designed to comply with US FDA, EU EMA & UK MHRA guidance and aligns with the GAMP5 validation methodology, as well as being CFR 21 Part 11 compliant.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
28 Mar 2024 Contract award notice (F03) Earlier regulations 010273-2024

more from Catapult CT

all contracts from this buyer →

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.